Welcome to our dedicated page for National Resh news (Ticker: NRC), a resource for investors and traders seeking the latest updates and insights on National Resh stock.
NRC Health reports developments in healthcare experience improvement solutions for hospitals and health systems. Its updates cover products and services such as Patient Experience, Market Insights, Reputation, Leader Rounding, and The Governance Institute, a service that provides governance research, education, assessments, conferences, and advisory resources for not-for-profit hospital and health system boards.
Company news commonly includes quarterly operating results, Total Recurring Contract Value disclosures tied to renewable contracts, cash flow and adjusted performance measures, health system partnership expansions, online reputation and consumer insight initiatives, industry recognition, governance publications, and capital allocation actions such as share repurchase authorizations.
Summary not available.
National Research Corporation (NASDAQ:NRC) announced a quarterly cash dividend of $0.12 per share, payable on January 14, 2022. Shareholders recorded by the close of business on December 30, 2021 will qualify for this payment. The corporation has been a prominent provider of analytics and insights aimed at enhancing human understanding for over 40 years.
NRC Health has awarded the 2021 Rising Stars Scholarship to Hunter Bergman and Lauren Lewis, both students at the University of Nebraska-Lincoln. Each recipient will receive $2,000 for the spring 2022 semester. The scholarship aims to support students interested in business development, marketing, and entrepreneurship. Hunter, a senior marketing major, is the President of StartupsUNL, while Lauren is a junior marketing major and has worked on campaigns for international non-profits. The program, initiated in 2011, highlights NRC Health's commitment to education and student engagement.
National Research Corporation (NASDAQ:NRC) reported a strong Q3 2021, with total recurring contract value reaching $151.5 million. Revenue increased 13% to $37.8 million, while operating income rose 9% to $13.1 million. The company experienced a 20% growth in Voice of the Customer offerings, gaining new clients like Sharp Healthcare and UConn Health. Year-to-date revenue increased 11% to $109.7 million. However, net income saw a slight decrease to $27.8 million compared to $29 million in 2020, attributed to a higher effective tax rate.
Summary not available.
National Research Corporation (NASDAQ:NRC) has declared a quarterly cash dividend of $0.12 per share. This dividend will be payable on October 15, 2021, to shareholders of record by the close of business on September 30, 2021. NRC has established itself as a leading provider of analytics and insights to enhance human understanding for over 40 years, showcasing its commitment to shareholder returns.
Summary not available.
Summary not available.
Summary not available.
National Research Corporation reported strong Q2 2021 results, achieving a 17% revenue increase to $36.4 million and a 32% rise in operating income to $12.2 million. The total recurring contract value grew 5% to $149.8 million, driven by a 29% boost in Voice of the Customer offerings. The cash balance increased to $48.9 million. However, the effective tax rate rose to 25% from 10% in the previous year, impacting net income which reached $8.9 million, up from $7.7 million. The company focuses on organic growth and enhancing client relationships.